• The University of Western Australia (M709), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


Current projects

ORCHID Study: Optimisation of screening and management of hyperglycaemia in pregnancy for rural communities

The ORCHID Study is a collaborative research project between the Rural Clinical School of WA and the Kimberley Aboriginal Medical Services, aimed at improving screening for hyperglycaemia (high blood-glucose levels) in pregnancy.

Hyperglycaemia first detected in pregnancy is associated with a range of adverse neonatal and maternal outcomes. Due to the potential to improve birth outcomes, screening for hyperglycaemia is recommended for all women without known diabetes using an oral glucose tolerance test (OGTT) at 24-28 weeks gestation and at first antenatal presentation if risk-factors are present. The OGTT requires women to fast overnight, consume a 75g glucose drink and have three blood samples taken over two hours.

Phase 1 of the ORCHID Study (2015-2018) was funded by a UWA multi-site grant, the Lishman Health Foundation and Diabetes Australia. Recruitment for Phase 1 is now complete. We found that:

Phase 2 of the ORCHID Study (2020-2022) is funded by Diabetes Research WA. We aim to validate thresholds for glycated albumin and HbA1c collected after 24-weeks gestation as alternative tests to the OGTT, when declined. Recruitment is now complete and final analysis will proceed once samples have been batch tested.

Phase 3 of the ORCHID Study (2022-2027), funded by the WA Department of Health and the Medical Research Futures Fund, aims to co-design culturally appropriate management strategies for Aboriginal women with hyperglycaemia detected early in pregnancy, and roll out alternative testing strategies Nation-wide.


Dr Emma Jamieson resides in the Southwest region of Western Australia and is a Future Health Research and Innovation Translational Research Fellow with the Rural Clinical School of WA. She has a personal interest in diabetes research and clinical management, and 15+ years laboratory experience in type 1 diabetes research and pancreatic islet transplantation models at both St Vincent’s Institute in Victoria and Harry Perkins Institute of Medical Research in Perth. Emma was awarded her PhD in 2022.

Emma is also MRFF Co-Lead for the ORCHID study which aims to  optimise screening and management of hyperglycaemia in pregnancy in rural and remote antenatal patients. Her focus is on translational research, aimed at improving birth outcomes and preventing or delaying progression to type 2 diabetes in mothers and babies.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Medical Science, BSc(hons), Curtin University

Award Date: 1 Nov 1997

Industry keywords

  • Diagnostics
  • Health

Research expertise keywords

  • Gestational diabetes
  • Type 1 diabetes


Dive into the research topics where Emma Jamieson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or